JWPharm Inc. (CEO Yu, Chang-yong), a company specializing in Korean medicinal production,

and Genoheal Inc. (CEO Ahn Jong-eop), a startup enterprise developing disorder treatments for women,

 have announced their agreement to partner in trial development for the PLCR, a subfertility drug made with natural ingredients, for the new drug clinial trial (phase II)

The preclinical trial of PLCR by Genoheal’s lab showed positive results, based on which Phase II clinical trial was approved after

 the IND request was submitted to the Ministry of Food and Drug Safety in December. With this partnership with JWPharm…

더보기

기자 : 김현경 ㅣ 보도일자 : 2022.04.21
출처 : 서울파이낸스(http://www.seoulfn.com)